ONCAlert | 2017 San Antonio Breast Cancer Symposium

Comprehensive Genomic Profiling With Loss of Heterozygosity for Ovarian Cancer Treatment

Julia Elvin, MD, PhD
Published Online:2:07 PM, Fri June 16, 2017

Julia Elvin, MD, PhD, vice president and senior associate medical director, Foundation Medicine, discusses a study of comprehensive genomic profiling with loss of heterozygosity to identify therapeutically relevant subsets of ovarian cancer.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.